Page last updated: 2024-10-19

niacin and Hematologic Malignancies

niacin has been researched along with Hematologic Malignancies in 1 studies

Niacin: A water-soluble vitamin of the B complex occurring in various animal and plant tissues. It is required by the body for the formation of coenzymes NAD and NADP. It has PELLAGRA-curative, vasodilating, and antilipemic properties.
vitamin B3 : Any member of a group of vitamers that belong to the chemical structural class called pyridines that exhibit biological activity against vitamin B3 deficiency. Vitamin B3 deficiency causes a condition known as pellagra whose symptoms include depression, dermatitis and diarrhea. The vitamers include nicotinic acid and nicotinamide (and their ionized and salt forms).
nicotinic acid : A pyridinemonocarboxylic acid that is pyridine in which the hydrogen at position 3 is replaced by a carboxy group.

Research Excerpts

ExcerptRelevanceReference
" In mice, optimization of OT-82 dosing and dietary niacin further expanded the compound's therapeutic index."1.56OT-82, a novel anticancer drug candidate that targets the strong dependence of hematological malignancies on NAD biosynthesis. ( Andrianova, EL; Antoch, MP; Chernov, MV; Chernova, OB; Gudkov, AV; Gupta, M; Haber, M; Henderson, MJ; Joshi, S; Kazyulkin, D; Komarov, PG; Kononov, E; Korotchkina, L; Krasnov, P; Lock, RB; Middlemiss, S; Norris, MD; Polinsky, A; Somers, K; Tian, Y; Toshkov, I; Veith, J; Vujcic, S, 2020)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Korotchkina, L1
Kazyulkin, D1
Komarov, PG1
Polinsky, A1
Andrianova, EL1
Joshi, S1
Gupta, M1
Vujcic, S1
Kononov, E1
Toshkov, I1
Tian, Y1
Krasnov, P1
Chernov, MV1
Veith, J1
Antoch, MP1
Middlemiss, S1
Somers, K1
Lock, RB1
Norris, MD1
Henderson, MJ1
Haber, M1
Chernova, OB1
Gudkov, AV1

Other Studies

1 other study available for niacin and Hematologic Malignancies

ArticleYear
OT-82, a novel anticancer drug candidate that targets the strong dependence of hematological malignancies on NAD biosynthesis.
    Leukemia, 2020, Volume: 34, Issue:7

    Topics: Animals; Antineoplastic Agents; Apoptosis; Benzamides; Cell Proliferation; Cytokines; Female; Hemato

2020